Discover sources of inflammatory disease progression that translate to therapeutic insights

IsoPlexis detects the small groups of highly dysfunctional immune cells that drive progression across inflammatory diseases, translating this information to therapeutic insights to help you advance your discovery & development programs.


See What’s Next in Inflammation & Autoimmune Response

Explore by Complex Autoimmune and Inflammatory Cancer Indications & Progressions

Use cases & research data

Explore by Inflammatory Diseases

“Quality assays are mainly descriptive with some objective parameters like cytokine production, cytotoxicity, and proliferation. Only recently, with PSI … can we start to differentiate products.”


Discover. Optimize. Predict.

IsoPlexis is empowering Inflammatory & Autoimmune Disease Research across the discover-optimize-predict continuum

Discover Differences

Naivs vs Tcm vs cTfh

Detect the small potent cell subsets that make the difference

Discover differences in T cell subtypes that correlate with SLE (systemic lupus) progression.

Follow Our Data

Optimize Targeting

Healthy Donor vs Untreated MS Donor

Optimize targeting in Inflammatory & Autoimmune Disease

Reveal optimal targets by uncovering the innate cell mechanism driving disease progression.

Follow Our Data

Predict Response

Grade < 3 CRS and Grade > CRS

Correlate data with response to predict clinical outcome

Stratify patients by CRS (cytokine release syndrome) in cell therapy, pre-infusion.

Follow Our Data

Explore Resources

Identify the Most Potent Cell Subsets in Your Samples

Our award-winning, single-cell system effortlessly delivers the data you need.

See How